Searched for
CYCLOSPORINE
Sun Pharma most exposed Indian company to Trump's new tariff threat, warns JefferiesIndian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...- Sun Pharma, Aurobindo recall drugs from US marketSun Pharmaceutical Industries and Aurobindo Pharma are recalling products from the US market due to manufacturing issues. Sun Pharma's subs...
- Sun Pharma launches novel therapy for dry eye disease in IndiaDED is caused when the quantity or quality of tears fails to keep the surface of the eye properly lubricated, and associated with symptoms ...
- Concord Biotech files DRHP with Sebi for Rs 2,000-2,500 cr IPOSources told ET that the IPO would be of ₹2000 crore - ₹2500 crore size.The issue with a face value of ₹1 per equity share is a complete of...
- Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with SebiAs per an F&S report, Concord Biotech commands a market share of over 20 per cent by volume in 2021 across identified fermentation-based AP...
- Aurobindo, Sun Pharma recall products in US marketWhile Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Phar...
- Sun Pharma launches dry eye treatment product in CanadaThe product is the first dry eye treatment available in Canada that is delivered with nanomicellar (NCELL) technology, which improves the b...
- Lupin launches generic drug used for prevention of organ rejection in kidney transplant in USDrug firm Lupin on Monday said it has launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection ...
- Sun Pharma launches Cequa to treat dry eye disease in USOne of the company's wholly-owned subsidiaries has commercialised Cequa 0.09 per cent in the US, Sun Pharma said in a filing to BSE.
- Sun Pharma erases gains to close in the redShares of Sun Pharma closed 0.45 per cent down at Rs 401 on BSE.
- Sun Pharma arm enters pact with China Medical SystemChina Medical System will pay Sun Pharma an initial upfront payment, regulatory and sales milestone payments, and royalties on net sales, t...
- Sun Pharma receives USFDA nod ophthalmic solution used to treat dry eye diseaseNew Delhi, Aug 16 () Sun Pharma has received approval from the US health regulator for CEQUA (cyclosporine ophthalmic solution), used to in...
- Sun Pharma climbs 2% on USFDA approvalThe drug in question is CEQUA (cyclosporine ophthalmic solution) 0.09 per cent.
- Sun Pharma climbs 3% after USFDA accepts new drug applicationhares of the company opened at Rs 545 and touched a high and low of Rs 559.30 and Rs 543.15, respectively, in trade so far.
- USFDA accepts Sun Pharma arm's ophthalmic drug applicationSun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division...
- Zydus Cadila gets USFDA nod for Mycophenolate MofetilThe approval is for Mycophenolate Mofetil injection of strength 500mg/vial, the company said in a BSE filing.
- Market hits 2-month high on firm global cues, Sensex jumps 245 pts, Nifty above 8,250Metal stocks remained in demand after copper edged higher in global commodities markets. JSW Steel, Jindal Steel, Vedanta and Tata Steel ga...
- Sun Pharma to buy Ocular Technologies from Auven TherapeuticsSun will pay Auven $40 million upfront, contingent development milestones and sales milestones, in addition to royalties on sales of Secier...
- New research may lead to birth control 'pill' for menThe drugs are given to transplant recipients to reduce the risk that the patient's body will reject its new organ.
- Drug-infused nano-particle to treat sore eyesResearchers have developed a topical solution containing nanoparticles that will combat dry eye syndrome with only one application a week.
Load More
